Reynolds Cameron John 4
4 · VOLITIONRX LTD · Filed Feb 13, 2019
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
Reynolds Cameron John
DirectorPresident and CEO
Transactions
- Award
Stock Options (Right to Buy)
2019-02-11+50,000→ 50,000 totalExercise: $3.25From: 2020-02-11Exp: 2025-02-11→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]A total of 50,000 Options were granted on February 11, 2019 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the grant date.